BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 219 filers reported holding BLUEBIRD BIO INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $39,456,000 | -20.6% | 221,541 | -38.8% | 0.40% | -29.4% |
| Q3 2017 | $49,697,000 | +9.9% | 361,825 | -15.9% | 0.56% | +0.9% |
| Q2 2017 | $45,220,000 | +21.5% | 430,462 | +5.2% | 0.56% | +10.2% |
| Q1 2017 | $37,205,000 | +33.0% | 409,295 | -9.7% | 0.51% | +14.9% |
| Q4 2016 | $27,972,000 | +4.0% | 453,354 | +14.2% | 0.44% | -9.6% |
| Q3 2016 | $26,902,000 | +10.9% | 396,897 | -29.1% | 0.49% | -0.4% |
| Q2 2016 | $24,249,000 | +14.1% | 560,164 | +12.0% | 0.49% | +4.0% |
| Q1 2016 | $21,261,000 | +33.3% | 500,253 | +101.4% | 0.47% | +8.3% |
| Q4 2015 | $15,948,000 | +5636.7% | 248,328 | +14950.2% | 0.44% | +6128.6% |
| Q2 2015 | $278,000 | -41.4% | 1,650 | -86.6% | 0.01% | -50.0% |
| Q2 2014 | $474,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |